Neurofibromatosis Clinical Trials Neurofibromatosis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy
Condition:   Cutaneous Neurofibroma Intervention:   Device: TOOsonix System ONE-M Sponsors:   Joergen Serup;   Sahlgrenska University Hospital, Sweden Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2021 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis
Condition:   Type I Neurofibromatosis Intervention:   Drug: TQ-B3234 capsule Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2021 Category: Research Source Type: clinical trials